Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (1-10 of 564) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R Brunner
Postgraduate Medicine|October 1, 1974
Renin suppressionH R Brunner
Revue Medicale De La Suisse Romande|November 1, 1978
[Arterial hypertension in chronic renal insufficiency]H R Brunner
Hospital Practice (Office Ed.)|August 15, 1990
The renin-angiotensin system in hypertension: an updateH R Brunner
Journal of Human Hypertension|August 1, 1993
Role of vasoactive peptides in blood pressure controlH R Brunner
Revue Medicale De La Suisse Romande|December 1, 1977
[Causes favoring urinary infections and their treatment]H R Brunner
Revue Medicale De La Suisse Romande|September 1, 1976
[Is prevention of chronic renal insufficiency possible?]H R Brunner
American Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R Brunner
American Journal of Hypertension|June 2, 1998
Endothelin inhibition as a biologic target for treating hypertensionH R Brunner
Kidney International|August 1, 1992
ACE inhibitors in renal diseaseH R Brunner
Pageof 57

Showing results (1-10 of 564) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R Brunner
Postgraduate Medicine|October 1, 1974
Renin suppressionH R Brunner
Revue Medicale De La Suisse Romande|November 1, 1978
[Arterial hypertension in chronic renal insufficiency]H R Brunner
Hospital Practice (Office Ed.)|August 15, 1990
The renin-angiotensin system in hypertension: an updateH R Brunner
Journal of Human Hypertension|August 1, 1993
Role of vasoactive peptides in blood pressure controlH R Brunner
Revue Medicale De La Suisse Romande|December 1, 1977
[Causes favoring urinary infections and their treatment]H R Brunner
Revue Medicale De La Suisse Romande|September 1, 1976
[Is prevention of chronic renal insufficiency possible?]H R Brunner
American Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R Brunner
American Journal of Hypertension|June 2, 1998
Endothelin inhibition as a biologic target for treating hypertensionH R Brunner
Kidney International|August 1, 1992
ACE inhibitors in renal diseaseH R Brunner
Pageof 57